Page 2 - Mankind Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mankind pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mankind Pharmaceuticals Today - Breaking & Trending Today

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years


Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
Track the industry of your choice with a daily newsletter specific to that
industry.
Stay on top of your investments. Track stock prices in your portfolio.
NOTE :
The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer s permission we will charge your card/ payment instrument each month automatically and renew your subscription.
In the Annual duration product we offer both an auto renewal based product and a non auto renewal based product. ....

Mankind Pharmaceuticals , Drugs Controller General , Standard Premium Digital , Seamless Sign Up , Business Standard Digital , Debit Cards , Net Banking , Payment Wallets , Business Standard , Generic Medicines , Pharma Companies , Hronic Therapy Drugs , மனிதகுலம் மருந்துகள் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , தடையற்ற அடையாளம் மேலே , வணிக தரநிலை டிஜிட்டல் , பற்று அட்டைகள் , நிகர வங்கி , கட்டணம் பணப்பைகள் , வணிக தரநிலை ,

Top headlines: Second Covid wave stings indices; Delhi goes under lockdown


Monday blues: Second Covid-19 wave stings indices as markets drop 1.8%
The worsening coronavirus crisis triggered yet another sell-off in the domestic stock market on Monday, with the benchmark indices dropping more than 3 per cent before recouping some of the losses. A sharp jump in Covid-19 cases and fresh curbs to contain the spread of the virus have stoked concerns about the revival of the economy and corporate earnings, prompting some investors to pull back.
Delhi under lockdown for a week as rising Covid cases stretch health infra
With more than 25,000 daily Covid cases stretching Delhi’s health infrastructure to its limit, patients gasping for oxygen, and bed occupancy running full, the national capital went into a week-long lockdown, starting 10 pm on Monday until 5 am on April 26. Meanwhile, the high court in Telangana gave a two-day ultimatum to the state government to decide on a lockdown or curfew. ....

Andhra Pradesh , Insurance Corporation Of India , India Inc , Delhi High Court , Supreme Court , Mankind Pharmaceuticals , Serum Institute Of India , Bharat Biotech , Serum Institute , Prime Minister Narendra Modi , General Insurance Corporation , Drugs Controller General , Future Retail , Top Business Headlines , Top Headlines , Farm Crisis , Agriculture Reforms , Farmer Protests , Stock Market , ஆந்திரா பிரதேஷ் , காப்பீடு நிறுவனம் ஆஃப் இந்தியா , இந்தியா இன்க் , டெல்ஹி உயர் நீதிமன்றம் , உச்ச நீதிமன்றம் , மனிதகுலம் மருந்துகள் , சீரம் நிறுவனம் ஆஃப் இந்தியா ,